Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: A clinical case study

Medical Physics

Volumn 40, Issue 7, 2013, Pages

  Kotopoulis, Spiros ^a,b,c   Dimcevski, Georg ^a,b   Helge Gilja, Odd ^a,b   Hoem, Dag ^a,b   Postema, Michiel ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Department of Clinical Medicine ^*  (Norway)

Author keywords

chemotherapy; microbubbles; sonoporation; ultrasound

Indexed keywords

CHEMOTHERAPY; PATIENT MONITORING; SCANNING;

CHEMOTHERAPY TREATMENT; EASTERN COOPERATIVE ONCOLOGY GROUP; MICROBUBBLES; PANCREATIC ADENOCARCINOMA; PANCREATIC CANCERS; SONOPORATION; ULTRASOUND CONTRAST AGENT; ULTRASOUND SCANNERS;

ULTRASONICS;

ECHO CONTRAST MEDIUM; GEMCITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SIZE; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MICROBUBBLE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; QUALITY OF LIFE; ULTRASOUND SCANNER; AGED; DISEASE COURSE; FEMALE; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; ULTRASOUND THERAPY; ANALOGS AND DERIVATIVES; PANCREATIC NEOPLASMS; THERAPEUTIC USE;

AGED; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MICROBUBBLES; MIDDLE AGED; PANCREATIC NEOPLASMS; ULTRASONIC THERAPY;

EID: 84880232215     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.4808149     Document Type: Article

References (53)

1. World Health Organization, World Health Statistics (World Health Organization, Geneva, Switzerland, 2012) (available URL: http://www.who.int/gho/ publications/world-health-statistics/2012/en/index.html).
2. D. Hariharan, A. Saied, and H. M. Kocher, " Analysis of mortality rates for pancreatic cancer across the world.," HPB (Oxford) 10, 58-62 (2008). 10.1080/13651820701883148
3. J. P. Neoptolemos, J. A. Dunn, D. D. Stocken, J. Almond, K. Link, H. Beger, C. Bassi, M. Falconi, P. Pederzoli, C. Dervenis, L. Fernandez-Cruz, F. Lacaine, A. Pap, D. Spooner, D. J. Kerr, H. Friess, M. W. Buchler, and European Study Group for Pancreatic Cancer, " Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial.," Lancet 358, 1576-1585 (2001). 10.1016/S0140-6736(01)06651-X
4. J. P. Neoptolemos, D. D. Stocken, H. Friess, C. Bassi, J. A. Dunn, H. Hickey, H. Beger, L. Fernandez-Cruz, C. Dervenis, F. Lacaine, M. Falconi, P. Pederzoli, A. Pap, D. Spooner, D. J. Kerr, M. W. Buchler, and European Study Group for Pancreatic Cancer, " A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.," N. Engl. J. Med. 350, 1200-1210 (2004). 10.1056/NEJMoa032295
5. S. Bao, B. D. Thrall, and D. L. Miller, " Transfection of a reporter plasmid into cultured cells by sonoporation in vitro.," Ultrasound Med. Biol. 23, 953-959 (1997). 10.1016/S0301-5629(97)00025-2
6. A. van Wamel, K. Kooiman, M. Harteveld, M. Emmer, F. J. ten Cate, M. Versluis, and N. de Jong, " Vibrating microbubbles poking individual cells: Drug transfer into cells via sonoporation.," J. Controlled Release 112, 149-155 (2006). 10.1016/j.jconrel.2006.02.007
7. A. Delalande, S. Kotopoulis, T. Rovers, C. Pichon, and M. Postema, " Sonoporation at a low mechanical index.," Bub. Sci. Eng. Tech. 3, 3-11 (2011). 10.1179/1758897911Y.0000000001
8. M. Postema, S. Kotopoulis, A. Delalande, and O. H. Gilja, " Sonoporation: Why microbubbles create pores.," Ultraschall Med. 33, 97-98 (2012). 10.1055/s-0031-1274749
9. N. G. Lee, J. L. Berry, T. C. Lee, A. T. Wang, S. Honowitz, A. L. Murphree, N. Varshney, D. R. Hinton, and A. A. Fawzi, " Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro.," Invest. Ophthalmol. Visual Sci. 52, 3868-3873 (2011). 10.1167/iovs.10-6501
10. C. X. Deng, F. Sieling, H. Pan, and J. Cui, " Ultrasound-induced cell membrane porosity.," Ultrasound Med. Biol. 30, 519-526 (2004). 10.1016/j.ultrasmedbio.2004.01.005
11. R. K. Schlicher, H. Radhakrishna, T. P. Tolentino, R. P. Apkarian, V. Zarnitsyn, and M. R. Prausnitz, " Mechanism of intracellular delivery by acoustic cavitation.," Ultrasound Med. Biol. 32, 915-924 (2006). 10.1016/j.ultrasmedbio.2006.02.1416
12. Y. Z. Zhao, Y. K. Luo, C. T. Lu, J. F. Xu, J. Tang, M. Zhang, Y. Zhang, and H. D. Liang, " Phospholipids-based microbubbles sonoporation pore size and reseal of cell membrane cultured in vitro.," J. Drug Target. 16, 18-25 (2008). 10.1080/10611860701637792
13. M. Postema and O. H. Gilja, " Ultrasound-directed drug delivery.," Curr. Pharm. Biotechnol. 8, 355-361 (2007). 10.2174/138920107783018453
14. M. Postema, O. H. Gilja, and A. van Wamel, " CEUS and sonoporation.," in Fundamentals of Medical Ultrasonics, edited by, M. Postema, (Spon, London, 2011), pp. 205-217.
15. M. Postema, S. Kotopoulis, A. Delalande, and O. H. Gilja, " Ultrasound-guided delivery and sonoporation.," Ultrasound in Gastroenterology: 10-years Anniversary of National Center for Ultrasound in Gastroenterology (National Center for Ultrasound in Gastroenterology, Bergen, Norway, 2011), pp. 57-59.
16. J. M. Escoffre, A. Novell, J. Piron, A. Zeghimi, A. Doinikov, and A. Bouakaz, " Microbubble attenuation and destruction: Are they involved in sonoporation efficiency," IEEE Trans. Ultrason. Ferroelectr. Freq. Control 60, 46-52 (2013). 10.1109/TUFFC.2013.2536
17. D. L. Miller and C. Dou, " Membrane damage thresholds for 1- to 10-MHz pulsed ultrasound exposure of phagocytic cells loaded with contrast agent gas bodies in vitro.," Ultrasound Med. Biol. 30, 973-977 (2004). 10.1016/j.ultrasmedbio.2004.05.010
18. D. L. Miller and C. Dou, " Membrane damage thresholds for pulsed or continuous ultrasound in phagocytic cells loaded with contrast agent gas bodies.," Ultrasound Med. Biol. 30, 405-411 (2004). 10.1016/j.ultrasmedbio. 2003.11.013
19. D. L. Miller, C. Dou, and J. Song, " DNA transfer and cell killing in epidermoid cells by diagnostic ultrasound activation of contrast agent gas bodies in vitro.," Ultrasound Med. Biol. 29, 601-607 (2003). 10.1016/S0301-5629(02)00783-4
20. D. L. Miller and J. Quddus, " Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies.," Ultrasound Med. Biol. 26, 661-667 (2000). 10.1016/S0301-5629(99)00170-2
21. M. W. Miller, " Gene transfection and drug delivery.," Ultrasound Med. Biol. 26, S59-S62 (2000). 10.1016/S0301-5629(00)00166-6
22. K. Kooiman, M. Harteveld, A. F. W. van der Steen, and N. de Jong, " Sonoporation of endothelial cells by vibrating targeted microbubbles.," J. Controlled Release 154, 35-41 (2011). 10.1016/j.jconrel.2011.04.008
23. A. Delalande, A. Bouakaz, G. Renault, F. Tabareau, S. Kotopoulis, P. Midoux, B. Arbeille, R. Uzbekov, S. Chakravarti, M. Postema, and C. Pichon, " Ultrasound and microbubble-assisted gene delivery in Achilles tendons: Long lasting gene expression and restoration of fibromodulin KO phenotype.," J. Controlled Release 156, 223-230 (2011). 10.1016/j.jconrel.2011.08.020
24. S. M. Nejad, S. H. R. Hosseini, H. Akiyama, and K. Tachibana, " Optical observation of cell sonoporation with low intensity ultrasound.," Biochem. Biophys. Res. Commun. 413, 218-223 (2011). 10.1016/j.bbrc.2011.08.072
25. F. Yang, N. Gu, D. Chen, X. Xi, D. Zhang, Y. Li, and J. Wu, " Experimental study on cell self-sealing during sonoporation.," J. Controlled Release 131, 205-210 (2008). 10.1016/j.jconrel.2008.07.038
26. Y. Qiu, C. Zhang, J. Tu, and D. Zhang, " Microbubble-induced sonoporation involved in ultrasound-mediated DNA transfection in vitro at low acoustic pressures.," J. Biomech. 45, 1339-1345 (2012). 10.1016/j.jbiomech.2012.03.011
27. M. Matsuo, K. Yamaguchi, L. B. Feril, Jr., H. Endo, K. Ogawa, K. Tachibana, and J. Nakayama, " Synergistic inhibition of malignant melanoma proliferation by melphalan combined with ultrasound and microbubbles.," Ultrason. Sonochem. 18, 1218-1224 (2011). 10.1016/j.ultsonch.2011.03.005
28. ® microbubbles.," J. Drug Target. 21 (4), 407-414 (2013). 10.3109/1061186X.2012.761223
29. Y. Watanabe, A. Aoi, S. Horie, N. Tomita, S. Mori, H. Morikawa, Y. Matsumura, G. Vassaux, and T. Kodama, " Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin.," Cancer Sci. 99, 2525-2531 (2008). 10.1111/j.1349-7006.2008.00989.x
30. J. Wu, J. Pepe, and M. Rincon, " Sonoporation, anti-cancer drug and antibody delivery using ultrasound.," Ultrasonics 44, E21-E25 (2006). 10.1016/j.ultras.2006.06.033
31. C. Y. Lai, C. H. Wu, C. C. Cheng, and P. C. Li, " Quantitative relations of acoustic inertial cavitation with sonoporation and cell viability.," Ultrasound Med. Biol. 32, 1931-1941 (2006). 10.1016/j.ultrasmedbio.2006.06.020
32. D. M. Hallow, A. D. Mahajan, T. E. McCutchen, and M. R. Prausnitz, " Measurement and correlation of acoustic cavitation with cellular bioeffects.," Ultrasound Med. Biol. 32, 1111-1122 (2006). 10.1016/j.ultrasmedbio.2006.03.008
33. M. M. Forbes, R. L. Steinberg, and W. D. O'Brien, " Examination of inertial cavitation of optison in producing sonoporation of Chinese hamster ovary cells.," Ultrasound Med. Biol. 34, 2009-2018 (2008). 10.1016/j.ultrasmedbio.2008.05.003
34. J. L. Tlaxca, C. R. Anderson, A. L. Klibanov, B. Lowrey, J. A. Hossack, J. S. Alexander, M. B. Lawrence, and J. J. Rychak, " Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles.," Ultrasound Med. Biol. 36, 1907-1918 (2010). 10.1016/j.ultrasmedbio.2010.05.014
35. C. D. Ohl and B. Wolfrum, " Detachment and sonoporation of adherent HeLa-cells by shock wave-induced cavitation.," Biochim. Biophys. Acta 1624, 131-138 (2003). 10.1016/j.bbagen.2003.10.005
36. D. L. Miller and C. Y. Dou, " Induction of apoptosis in sonoporation and ultrasonic gene transfer.," Ultrasound Med. Biol. 35, 144-154 (2009). 10.1016/j.ultrasmedbio.2008.06.007
37. M. Postema and O. H. Gilja, " Jetting does not cause sonoporation.," Biomed. Eng. 55, S19-S20 (2010). 10.1515/bmt.2010.710
38. B. Geers, H. Dewitte, S. C. De Smedt, and I. Lentacker, " Crucial factors and emerging concepts in ultrasound-triggered drug delivery.," J. Controlled Release 164, 248-255 (2012). 10.1016/j.jconrel.2012.08.014
39. F. G. Erchinger, G. Dimcevski, T. Engjom, and O. H. Gilja, " Transabdominal ultrasonography of the pancreas: Basic and new aspects.," Imaging Med. 3, 411-422 (2011). 10.2217/iim.11.36
40. M. Postema and O. H. Gilja, " Contrast-enhanced and targeted ultrasound.," World J. Gastroenterol. 17, 28-41 (2011). 10.3748/wjg.v17.i1.28
41. F. Piscaglia, C. Nolsoe, C. F. Dietrich, D. O. Cosgrove, O. H. Gilja, M. Bachmann Nielsen, T. Albrecht, L. Barozzi, M. Bertolotto, O. Catalano, M. Claudon, D. A. Clevert, J. M. Correas, M. D'Onofrio, F. M. Drudi, J. Eyding, M. Giovannini, M. Hocke, A. Ignee, E. M. Jung, A. S. Klauser, N. Lassau, E. Leen, G. Mathis, A. Saftoiu, G. Seidel, P. S. Sidhu, G. ter Haar, D. Timmerman, and H. P. Weskott, " The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications.," Ultraschall Med. 33, 33-59 (2012). 10.1055/s-0031-1281676
42. M. Postema, Fundamentals of Medical Ultrasonics (Spon, New York, 2011).
43. B. Gerold, S. Kotopoulis, C. McDougall, D. McGloin, M. Postema, and P. Prentice, " Laser-nucleated acoustic cavitation in focused ultrasound.," Rev. Sci. Instrum. 82, 044902 (2011). 10.1063/1.3579499
44. U.S. Department of Health and Human Services, Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers (Food and Drug Administration, 2008).
45. International Electrotechnical Commission, " Ultrasonics- Hydrophones-Part 2: Calibration for ultrasonic fields up to 40 MHz.," Report No. 62127-2 ed1.0 (IEC, Geneva, Switzerland, 2013).
46. J. A. Jensen, S. I. Nikolov, K. L. Gammelmark, and M. H. Pedersen, " Synthetic aperture ultrasound imaging.," Ultrasonics 44 (Suppl. 1), e5-e15 (2006). 10.1016/j.ultras.2006.07.017
47. E. Quaia, " Microbubble ultrasound contrast agents: An update.," Eur. Radiol. 17, 1995-2008 (2007). 10.1007/s00330-007-0623-0
48. Guidelines for the Safe Use of Diagnostic Ultrasound Equipment (British Medical Ultrasound Society, London, UK, 2000).
49. S. B. Barnett, G. R. Ter Haar, M. C. Ziskin, H. D. Rott, F. A. Duck, and K. Maeda, " International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine.," Ultrasound Med. Biol. 26, 355-366 (2000). 10.1016/S0301-5629(00)00204-0
50. Highlights of Prescribing Information: Gemzar (Eli Lilly and Company, Indianapolis, Indiana, 2010) (available URL: http://pi.lilly.com/us/gemzar.pdf).
51. M. M. Oken, R. H. Creech, D. C. Tormey, J. Horton, T. E. Davis, E. T. Mcfadden, and P. P. Carbone, " Toxicity and response criteria of the Eastern-Cooperative-Oncology-Group.," Am. J. Clin. Oncol. 5, 649-655 (1982). 10.1097/00000421-198212000-00014
52. E. A. Eisenhauer, P. Therasse, J. Bogaerts, L. H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, and J. Verweij, " New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1).," Eur. J. Cancer 45, 228-247 (2009). 10.1016/j.ejca.2008.10.026
53. S. A. Sohaib, B. Turner, J. A. Hanson, M. Farquharson, R. T. Oliver, and R. H. Reznek, " CT assessment of tumour response to treatment: Comparison of linear, cross-sectional and volumetric measures of tumour size.," Br. J. Radiol. 73, 1178-1184 (2000).